Asparagine endopeptidase cleaves synaptojanin 1 and triggers synaptic dysfunction in Parkinson's disease.
Aged
Animals
COS Cells
Cells, Cultured
Chlorocebus aethiops
Cysteine Endopeptidases
/ metabolism
Excitatory Postsynaptic Potentials
/ physiology
Female
HEK293 Cells
Humans
Male
Mice
Mice, 129 Strain
Mice, Inbred C3H
Mice, Knockout
Mice, Transgenic
Middle Aged
Parkinson Disease
/ genetics
Phosphoric Monoester Hydrolases
/ genetics
Synapses
/ metabolism
AEP
Neurodegeneration
Parkinson's disease
SYNJ1
Synaptic dysfunction
α-Synuclein transgenic mice
Journal
Neurobiology of disease
ISSN: 1095-953X
Titre abrégé: Neurobiol Dis
Pays: United States
ID NLM: 9500169
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
23
09
2020
revised:
02
02
2021
accepted:
02
03
2021
pubmed:
8
3
2021
medline:
20
1
2022
entrez:
7
3
2021
Statut:
ppublish
Résumé
Parkinson's disease (PD) is one of the most common neurodegenerative diseases, which is characterized by the loss of dopaminergic neurons in the nigrostriatal pathway. Synaptic dysfunction impairs dopamine turnover and contributes to the degeneration of dopaminergic neurons. However, the molecular mechanisms underlying synaptic dysfunction and dopaminergic neuronal vulnerability in PD are not clear. Here, we report that synaptojanin 1 (SYNJ1), a polyphosphoinositide phosphatase concentrated at nerve terminals, is a substrate of a cysteine proteinase, asparagine endopeptidase (AEP). SYNJ1 is cleaved by the cysteine proteinase AEP at N599 in the brains of PD patients. AEP-mediated cleavage of SYNJ1 disrupts neuronal phosphoinositide homeostasis and causes synaptic dysfunction. Overexpression of the AEP-generated fragments of SYNJ1 triggers synaptic dysfunction and the degeneration of dopaminergic neurons, inducing motor defects in the α-synuclein transgenic mice. Blockage of AEP-mediated cleavage of SYJN1 alleviates the pathological and behavioral defects in a mouse model of PD. Our results demonstrate that the fragmentation of SYNJ1 by AEP mediates synaptic dysfunction and dopaminergic neuronal degeneration in PD.
Identifiants
pubmed: 33677035
pii: S0969-9961(21)00075-9
doi: 10.1016/j.nbd.2021.105326
pii:
doi:
Substances chimiques
Phosphoric Monoester Hydrolases
EC 3.1.3.2
phosphoinositide 5-phosphatase
EC 3.1.3.36
Cysteine Endopeptidases
EC 3.4.22.-
asparaginylendopeptidase
EC 3.4.22.34
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
105326Informations de copyright
Copyright © 2021. Published by Elsevier Inc.